Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/11/2007US20070237757 Contact tumor cell expressing matrix metalloproteinase 1 with siRNA that has a sequence complementary to part of a matrix metalloproteinase 1 nucleic acid sequence specifically inhibiting synthesis or expression; cancer
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237753 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
10/11/2007US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007US20070237743 Combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
10/11/2007US20070237735 Anti-aging composition, kit and method of use
10/11/2007US20070237723 Treatment of cough with interferon
10/11/2007US20070235365 Rapid Acting Drug Delivery Compositions
10/11/2007US20070235035 Method Of Producing Auto Induced Physiological Processes In A Body Cavity And A Device For Using It
10/11/2007DE102006015140A1 Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen Heterocyclic compounds with activity against neurodegenerative diseases
10/11/2007CA2648351A1 Regulating fat and carbohydrate oxidation in muscle tissue
10/11/2007CA2647986A1 Compositions for tumor growth control
10/11/2007CA2647568A1 Amylin and amylin agonists for treating psychiatric diseases and disorders
10/11/2007CA2647465A1 Pharmaceutical composition containing the nmb0606 protein
10/11/2007CA2647146A1 Linear natriuretic peptide constructs
10/11/2007CA2647143A1 Cyclic natriuretic peptide constructs
10/11/2007CA2647142A1 Vegf receptor fusion protein and use thereof
10/11/2007CA2645245A1 Compositions and methods for treating atherosclerosis
10/11/2007CA2644642A1 A process for concentration of a polypeptide
10/11/2007CA2642849A1 Suppression and treatment of neuropathic pain
10/11/2007CA2639925A1 Technology for preparation of macromolecular microspheres
10/11/2007CA2632528A1 A process for concentration of a polypeptide
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842911A1 Hla-binding peptides, dna fragments encoding the same and recombinant vectors
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842858A2 Methods and compositions for treating oral and esophageal lesions
10/10/2007EP1842857A1 Mutant interferon proteins and use thereof
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1842555A1 Tolerance development inhibitor for narcotic analgesic agent
10/10/2007EP1842553A1 Combination of an anti-EDb fibronectin domain antibody/IL2 fusion protein and a further small molecule
10/10/2007EP1842552A1 Treatment for diabetes
10/10/2007EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007EP1842550A2 Composition for inducing immunotolerance
10/10/2007EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007EP1842548A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
10/10/2007EP1842538A2 Treatment for Raynaud's Phenomenon
10/10/2007EP1842066A2 Biologically active silver-coated proteins
10/10/2007EP1841880A2 Binding protein with a scaffold for varying specificity
10/10/2007EP1841875A2 Controlled production and delivery of biologically active agents by gut bacteria
10/10/2007EP1841868A2 Inhibitor nucleic acids
10/10/2007EP1841790A2 Ephb receptor-binding peptides
10/10/2007EP1841789A2 Hiv resistance genes
10/10/2007EP1841781A1 Use of il-22 for the treatment of conditions of metabolic disorders
10/10/2007EP1841462A2 Growth factor therapy mobilization of stem cells into the peripheral blood
10/10/2007EP1841449A2 Methods and compositions related to modulating the extracellular stem cell environment
10/10/2007EP1841448A2 Pharmaceutical compositions and methods for restoring beta-cell mass and function
10/10/2007EP1841447A1 Use of soluble cd164 variants in inflammatory and/or autoimmune disorders
10/10/2007EP1841446A1 Peptides and compounds that bind to the il-5 receptor
10/10/2007EP1841445A1 Therapeutic nutrient compositions or combinations and methods of their use
10/10/2007EP1841444A2 Formulations of peptides for periodontal and dental treatments
10/10/2007EP1841443A2 Method and system for treating heart failure
10/10/2007EP1841442A1 Treatment for autoimmune and inflammatory conditions
10/10/2007EP1841316A2 Regulation of ccn2 by ccn3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
10/10/2007EP1624897B1 Hiv prodrugs cleavable by cd26
10/10/2007EP1572957A4 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1401504B1 Uv-screening peptide-flavonoid conjugates
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1320384B1 The synergetic effects of hgf and antibacterial treatment
10/10/2007EP1272215B1 Pharmaceutical preparations comprising modified peptides
10/10/2007EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
10/10/2007EP1231927B1 Compositions comprising vernix and an uv protectant and their use
10/10/2007EP1229906B1 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
10/10/2007EP1225220B1 Elimination of gal alpha 1-3 gal from swine tissue with endo-beta-galactosidase c
10/10/2007EP1173195B1 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/10/2007EP1155322B1 Compounds and methods for diagnosing trypanosoma cruzi infection
10/10/2007EP1154764B1 Use of epoxide hydrolase complexes for treating hypertension
10/10/2007EP1090924B1 Tumor antigen peptides originating in cyclophilin b
10/10/2007EP1068241B1 Antibody variants and fragments thereof
10/10/2007EP1002064B1 A modified polypeptide
10/10/2007EP0978565B1 Process for producing peptide with the use of accessory peptide
10/10/2007EP0975792B1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
10/10/2007EP0967892B2 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/10/2007EP0669973B9 Biological factors and neural stem cells
10/10/2007CN200956805Y Active factor cream massaging bra with magnetic beads
10/10/2007CN101052651A Caspase-2 inhibitors and their biological applications
10/10/2007CN101052650A Novel peptide for treating obesity
10/10/2007CN101052649A Peptide for treating obesity
10/10/2007CN101052648A Novel peptide for treating obesity
10/10/2007CN101052647A Novel peptide for treating obesity
10/10/2007CN101052419A Antagonizing interleukin-21 receptor activity
10/10/2007CN101052417A Prevention and treatment of synucleinopathic and amyloidogenic disease
10/10/2007CN101052415A Methods and compositions for treating and preventing inflammatory conditions
10/10/2007CN101052410A Method for fostering bone formation and preservation
10/10/2007CN101052409A Methods of treating disease with random copolymers
10/10/2007CN101052408A Peptides that selectively home to heart vasculature and related conjugates and methods
10/10/2007CN101052386A Medicine composition for pediatric use based on nk2 antagonist
10/10/2007CN101052298A S1-5-containing protein preparation
10/10/2007CN101050239A Interfusion protein between diphtheria toxin and GM CSF mutant, coded gene and application
10/10/2007CN101050238A Interfusion protein between diphtheria toxin and GM CSF mutant, coded gene and application
10/10/2007CN101050237A Compound for blocking out interaction between uPA and uPAR, and application
10/10/2007CN101050236A Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application
10/10/2007CN101049502A Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/10/2007CN101049501A Composition of medicine for improving goodly hair quality of pet in mammalia, and method
10/10/2007CN101049500A Composition of amino acid
10/10/2007CN100342017C Gene recombined chemotaxis antigen vaccine
10/10/2007CN100341896C Anti-GP39 antibodies and uses therefor
10/10/2007CN100341890C Peptide specifically associated with front surface antigen zone of large protein of human hepatitis B virus surface antigen and uses thereof
1 ... 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 ... 3163